High dose of JCM-16021 treatment did not show any effect on the decreased SERT expression in PI-IBS rats, indicating that JCM-16021 treatment can decrease colonic EC cell number, 5-HT content, and TPH expression, but not SERT expression, in PI-IBS rats. This evidence concerns the gene TPH1 and irritable bowel syndrome.